Bishal Gyawali, MD, PhD, Advisory Board Member

Bishal Gyawali, MD, PhD, GRACE Advisory Board Member
Brigham and Women's Hospital, Queen’s University Cancer Research Institute, Kingston
Boston
MA
Specialties
Research Fellow at Brigham and Women's Hospital, Medical Oncologist, Assistant Professor, and scientist in the Division of Cancer Care and Epidemiology

Brigham and Women's Hospital

BRIGHAM AND WOMEN'S HOSPITAL


75 FRANCIS STREET, BOSTON MA 02115

 

MD,PhD. Med Onc. Asst. Professor @QueensUHealth. Scientist @QueensCRI.

Affiliated faculty @portal_research. Advocate of #cancergroundshot.  No #FCOI.


Dr Gyawali is a medical oncologist with work experience in various low- and high- income countries. He graduated medical school in Nepal with seven gold medals and received his PhD from Nagoya University, Japan as a MEXT scholar. He then practiced as a medical oncologist at Civil Service Hospital, Kathmandu, Nepal. He currently works as a medical oncologist and scientist in the Division of Cancer Care and Epidemiology at the Queen’s University Cancer Research Institute in Kingston, Ontario, Canada, where he is also an Assistant Professor of Public Health Sciences. He was a research fellow at PORTAL from 2018-2019.

He also serves as a medical consultant for the not-for-profit Anticancer Fund, Belgium, and as editorial board member for the Journal of Global Oncology and ecancer. His clinical and research interests include cancer policy, global oncology, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, and supportive care. Dr. Gyawali is an advocate of the "cancer groundshot,"  a term he coined to imply that research investment should be made on known high-value interventions in cancer care that are affordable and easy to implement globally. Dr. Gyawali is active in the oncology and clinical research communities on Twitter: @oncology_bg

https://www.portalresearch.org/bishal-gyawali.html

Community Forum

JOIN THE CONVERSATION

Hi Carole, Welcome to Grace. If the adrenal is the only place that cancer has been seen since your lobectomy it could be that it's what's known as a precocious metastasis/oligoprogression...

Carole,

These approaches haven't been directly compared, and it really depends on who can do the job and what they say is appropriate to expect in terms of side effects. In...

Hi CDaniele,
Welcome to Grace. If the TKI is working except for one or 2 places local treatment such as radiation can be used to get rid of the resistant cells...

I forgot to tell you that Grace is having its annual OncTalk live forum online Saturday, Dec. 11 at 8 am Pacific and 11 am Eastern
It will be invaluable to...

This is indeed a happy Thanksgiving in our house. I'll post about it at soon but we've just come out of a dark place and are feeling so hopeful today.
As...

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that we are here! You are a very important part of the GRACE...

Hi and welcome to Grace.  I'm sorry your sister-in-law is going through this it's so unsettling, to say the least.  Cancer travels through the lymph system but also through blood vessels. ...